CDMRP Peer Reviewed Medical Research Program: Technology/Therapeutic Development Award

The Technology/Therapeutic Development Award s a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY26 PRMRP Topic Areas and one of the FY26 PRMRP Strategic Goals.
 

Each investigator may be named on only one FY26 PRMRP application as PI
 

FY26 PRMRP Topic Areas

Autoimmune Disorders and Immunology

• Celiac Disease

• Eczema

• Food Allergies

• Inflammatory Bowel Disease

• Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune

Neuropsychiatric Disorder Associated with Streptococcus (PANDAS)

• Sarcoidosis

• Scleroderma

Cardiovascular Health

• Brain Injury Impact on Cardiac Health

• Hypoxia

Infectious Diseases

• Congenital Cytomegalovirus

• Hepatitis B

Internal Medicine

• Accelerated Aging Processes Associated with Military Service

• Endometriosis

• Hypertrophic Dyschromia

• Infertility Associated with Military Aviators and Aviation Support Personnel

• Interstitial Cystitis

• Pancreatitis

• Polycystic Kidney Disease

Neuroscience and Mental Health  

• Brain Injury Impact on Cardiac Health

• Dystonia

• Eating Disorders

• Gambling Addiction

• Hydrocephalus

• Intranasal Ketamine Anesthetics

• Maternal Mental Health

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

• PANS and PANDAS

• Peripheral Neuropathy

• Post-Traumatic Stress Disorder

• Sleep Disorders and Restrictions

• Suicide Prevention

Orthopaedic Medicine

• Accelerated Aging Processes Associated with Military Service

• Musculoskeletal Health

• Orthotics and Prosthetics Outcomes

Rare Diseases and Conditions

• Angelman Syndrome

• Ehlers-Danlos Syndrome

• Facioscapulohumeral Muscular Dystrophy

• Fibrous Dysplasia/McCune-Albright Syndrome

• Fragile X

• Frontotemporal Degeneration

• Hereditary and Acquired Ataxias

• Hereditary Hemorrhagic Telangiectasia

• Hermansky-Pudlak Syndrome

• Mitochondrial Disease

• Myotonic Dystrophy

• Prader-Willi Syndrome

• Rett Syndrome

• Sickle-Cell Disease

• Spinal Muscular Atrophy

• von Hippel-Lindau Disease

Research and Clinical Tools

• Proteomics

Respiratory and Environmental Health

• Burn Pit Exposure

• Hypoxia

• Pulmonary Fibrosis

• Respiratory Health

It is expected that 12 awards will be granted this year. 

Funding: $5,600,000
Duration: 4 years

Research authority due date: 16.7.26

LOI (required) due date: 23.7.26
Full proposal due date: 6.8.26